Cargando…
Liposome Lipid-Based Formulation Has the Least Influence on rAAV Transduction Compared to Other Transfection Agents
Recombinant adeno-associated virus (rAAV) vectors are considered ideal vehicles for human gene therapy. Meanwhile, non-viral strategies, such as transfection agents (TAs), have also shown promise to deliver genetic materials, such as siRNA. Transduction with the rAAV vector is performed concurrently...
Autores principales: | Guo, Pengpeng, Yu, Chenghui, Wang, Qingxin, Zhang, Ruirong, Meng, Xianze, Feng, Yinglu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054704/ https://www.ncbi.nlm.nih.gov/pubmed/30038940 http://dx.doi.org/10.1016/j.omtm.2018.04.004 |
Ejemplares similares
-
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013) -
rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020) -
Production of rAAV by plasmid transfection induces antiviral and inflammatory responses in suspension HEK293 cells
por: Chung, Cheng-Han, et al.
Publicado: (2023) -
Hippocampal GAD67 Transduction Using rAAV8 Regulates Epileptogenesis in EL Mice
por: Shimazaki, Kuniko, et al.
Publicado: (2019) -
PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery
por: Zou, Liang, et al.
Publicado: (2022)